Likelihood Methods in Survival Analysis Likelihood Methods in Survival Analysis
Chapman & Hall/CRC Biostatistics Series

Likelihood Methods in Survival Analysis

With R Examples

Jun Ma and Others
    • $69.99
    • $69.99

Publisher Description

Many conventional survival analysis methods, such as the Kaplan-Meier method for survival function estimation and the partial likelihood method for Cox model regression coefficients estimation, were developed under the assumption that survival times are subject to right censoring only. However, in practice, survival time observations may include interval-censored data, especially when the exact time of the event of interest cannot be observed. When interval-censored observations are present in a survival dataset, one generally needs to consider likelihood-based methods for inference. If the survival model under consideration is fully parametric, then likelihood-based methods impose neither theoretical nor computational challenges. However, if the model is semi-parametric, there will be difficulties in both theoretical and computational aspects.

Likelihood Methods in Survival Analysis: With R Examples explores these challenges and provides practical solutions. It not only covers conventional Cox models where survival times are subject to interval censoring, but also extends to more complicated models, such as stratified Cox models, extended Cox models where time-varying covariates are present, mixture cure Cox models, and Cox models with dependent right censoring. The book also discusses non-Cox models, particularly the additive hazards model and parametric log-linear models for bivariate survival times where there is dependence among competing outcomes.

Features
Provides a broad and accessible overview of likelihood methods in survival analysis Covers a wide range of data types and models, from the semi-parametric Cox model with interval censoring through to parametric survival models for competing risks Includes many examples using real data to illustrate the methods Includes integrated R code for implementation of the methods Supplemented by a GitHub repository with datasets and R code
The book will make an ideal reference for researchers and graduate students of biostatistics, statistics, and data science, whose interest in survival analysis extend beyond applications. It offers useful and solid training to those who wish to enhance their knowledge in the methodology and computational aspects of biostatistics.

GENRE
Science & Nature
RELEASED
2024
October 1
LANGUAGE
EN
English
LENGTH
400
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
7.3
MB
The Economics of Air Pollution in China The Economics of Air Pollution in China
2016
Fast, Low-Resource, Accurate Robust Organ and Pan-cancer Segmentation Fast, Low-Resource, Accurate Robust Organ and Pan-cancer Segmentation
2025
Medical Image Segmentation Foundation Models. CVPR 2024 Challenge: Segment Anything in Medical Images on Laptop Medical Image Segmentation Foundation Models. CVPR 2024 Challenge: Segment Anything in Medical Images on Laptop
2025
Social Robotics Social Robotics
2025
Fast, Low-resource, and Accurate Organ and Pan-cancer Segmentation in Abdomen CT Fast, Low-resource, and Accurate Organ and Pan-cancer Segmentation in Abdomen CT
2024
Automotive Human-Machine Interaction (HMI) Evaluation Method Automotive Human-Machine Interaction (HMI) Evaluation Method
2024
Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
2021
Medical Risk Prediction Models Medical Risk Prediction Models
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
2020
Biosimilar Clinical Development: Scientific Considerations and New Methodologies Biosimilar Clinical Development: Scientific Considerations and New Methodologies
2016
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
2021